Beken Bio develops surgical fluid tests that help diagnose cancer.
Beken Bio has raised $750K in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Beken Bio's investors include Boot64 Ventures, Curebound, Tulane Ventures, New Orleans BioFund, 1834 Ventures.
Beken Bio is headquartered in San Diego, United States.
Beken Bio develops surgical fluid tests that help diagnose cancer.
Beken Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beken Bio — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/beken-bio. Accessed August 18, 2026.
VCBacked. (2025). Beken Bio — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/beken-bio
{{cite web |title=Beken Bio — Funding & Investors |url=https://www.vcbacked.co/company/beken-bio |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated